SugarBEAT® is the World’s First Non-Invasive Continuous Glucose Monitor Loughborough,England, May 29, 2019 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics and pre-diabetics, today announced that it has received CE Mark … Continue reading Nemaura Announces CE Mark Approval of SugarBEAT®